Extracts of wild Egyptian plants from the desert inhibit the growth of Toxoplasma gondii and Neospora caninum in vitro

J Vet Med Sci. 2022 Jul 25;84(7):1034-1040. doi: 10.1292/jvms.22-0159. Epub 2022 Jun 6.

Abstract

Wild medicinal plants have been traditionally used as antimicrobial agents. Here, we evaluated the in vitro activity of extracts from wild Egyptian desert plants against Toxoplasma gondii and Neospora caninum. From 12 plant extracts tested, the methanolic extracts from Artemisia judaica, Cleome droserifolia, Trichodesma africanum, and Vachellia tortilis demonstrated potent activity against the growth of T. gondii, with half-maximal inhibitory concentrations (IC50s) of 2.1, 12.5, 21.8, and 24.5 µg/ml, respectively. C. droserifolia, an ethanolic extract of P. undulata, T. africanum, A. judaica, and V. tortilis demonstrated potent efficacy against N. caninum, with mean IC50s of 1.0, 3.0, 3.1, 8.6, and 17.2 µg/ml, respectively. Our data suggest these extracts could provide an alternative treatment for T. gondii and N. caninum infections.

Keywords: Egypt; Neospora caninum; Toxoplasma gondii; desert; plant extract.

MeSH terms

  • Animals
  • Antibodies, Protozoan
  • Coccidiosis* / drug therapy
  • Coccidiosis* / veterinary
  • Egypt
  • Neospora*
  • Plant Extracts / pharmacology
  • Seroepidemiologic Studies
  • Toxoplasma*
  • Toxoplasmosis, Animal*

Substances

  • Antibodies, Protozoan
  • Plant Extracts